Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAV, PSF, CFG

Notice to the media - Government of Canada officials to hold a technical briefing on COVID-19 vaccines in Canada


OTTAWA, ON, April 14, 2021 /CNW/ - Government of Canada officials will hold a technical briefing to provide an overview on the roll-out of COVID-19 vaccines.

Officials will be available to answer questions from the media following their remarks.

Date
April 15, 2021

Time
10:30 AM (EDT)

Location

The media technical briefing will be held virtually. Media will be able to ask questions via teleconference.

Toll-free (Canada/US) dial-in number:
1-866-206-0153
Local dial-in number:
613-954-9003

Passcode: 1622050#

To obtain the briefing material under embargo, please RSVP by email at
[email protected].

NOTE: To help ensure optimal simultaneous interpretation sound quality, journalists are encouraged to use a microphone (headphones/headset) or, when possible, a landline, and to avoid using speaker mode if queuing up for questions.

Twitter: @GovCanHealth
Facebook: Healthy Canadians

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 07:35
Agenus Inc. ("Agenus") , a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. Agenus executives...

at 07:34
Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An," the "Company" or the "Group," HKEX: 2318; SSE: 601318) today announced its first quarter financial results for the three months ended March 31, 2024....

at 07:31
Tharimmune, Inc. ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation & immunology, announced today an option agreement for an...

at 07:30
KFSH&RC participates as a strategic partner in the Saudi American Healthcare Forum, which will take place on April 25th under the patronage of the Ministry of Health in Riyadh. This forum aims to discuss the primary healthcare challenges facing the...

at 07:30
Factor Bioscience Inc., a Cambridge-based biotechnology company focused on...

at 07:15
Encoded Therapeutics Inc., a biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today unveiled multiple pipeline programs ahead of the 27th ASGCT Annual meeting on May 7 - 11, 2024 in Baltimore, MD....



News published on and distributed by: